Showing results (141-150 of 278) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|October 13, 2014
A filter-flow perspective of haematogenous metastasis offers a non-genetic paradigm for personalised cancer therapyJacob G Scott, Alexander G Fletcher, Philip K Maini, et al.
PRX Life|August 11, 2025
Frequency-Dependent Ecological Interactions Increase the Prevalence, and Shape the Distribution, of Preexisting Drug ResistanceJeff Maltas, Dagim Shiferaw Tadele, Arda Durmaz, et al.
Proteomes|February 4, 2017
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung CancerJae-Young Kim, Paul A Stewart, Adam L Borne, et al.
Oncotarget|July 1, 2021
Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
Plos One|November 6, 2015
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung AdenocarcinomaPaul A Stewart, Katja Parapatics, Eric A Welsh, et al.
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Bioinformatics (Oxford, England)|April 8, 2025
ROICellTrack: a deep learning framework for integrating cellular imaging modalities in subcellular spatial transcriptomic profiling of tumor tissuesXiaofei Song, Xiaoqing Yu, Carlos M Moran-Segura, et al.
Oncotarget|February 21, 2019
Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
The International Journal of Biochemistry & Cell Biology|August 26, 2024
Cell-cell fusion in cancer: The next cancer hallmark?Paulameena V Shultes, Davis T Weaver, Dagim S Tadele, et al.
Cancer Research|February 3, 2016
The Cancer Stem Cell Fraction in Hierarchically Organized Tumors Can Be Estimated Using Mathematical Modeling and Patient-Specific Treatment TrajectoriesBenjamin Werner, Jacob G Scott, Andrea Sottoriva, et al.
Pageof 28